Northern Trust
DNA icon

Northern Trust’s Ginkgo Bioworks DNA Stock Holding History

Northern Trust’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01M Buy
405,141
+70,963
+21% +$593K ﹤0.01% 2743
2026
Q1 		$2.05M Buy
334,178
+20,903
+7% +$174K ﹤0.01% 2966
2025
Q4 		$2.6M Sell
313,275
-12,233
-4% -$132K ﹤0.01% 2841
2025
Q3 		$4.75M Buy
325,508
+6,565
+2% +$78.6K ﹤0.01% 2532
2025
Q2 		$3.59M Buy
318,943
+217,817
+215% +$1.69M ﹤0.01% 2660
2025
Q1 		$576K Buy
101,126
+6,250
+7% +$63.7K ﹤0.01% 3517
2024
Q4 		$932K Buy
94,876
+9,791
+12% +$83.9K ﹤0.01% 3427
2024
Q3 		$693K Sell
85,085
-62,597
-42% -$627K ﹤0.01% 3477
2024
Q2 		$1.97M Sell
147,682
-1,483
-1% -$44.2K ﹤0.01% 2904
2024
Q1 		$6.92M Sell
149,165
-4,477
-3% -$232K ﹤0.01% 2279
2023
Q4 		$10.4M Buy
153,642
+4,892
+3% +$300K ﹤0.01% 2043
2023
Q3 		$10.8M Buy
148,750
+14,716
+11% +$1.18M ﹤0.01% 1952
2023
Q2 		$9.97M Buy
134,034
+23,728
+22% +$1.4M ﹤0.01% 2067
2023
Q1 		$5.87M Buy
110,306
+7,868
+8% +$499K ﹤0.01% 2358
2022
Q4 		$6.92M Buy
102,438
+25,088
+32% +$2.31M ﹤0.01% 2255
2022
Q3 		$9.65M Sell
77,350
-5,831
-7% -$695K ﹤0.01% 1992
2022
Q2 		$7.92M Buy
83,181
+33,257
+67% +$4.06M ﹤0.01% 2202
2022
Q1 		$8.05M Sell
49,924
-1,370
-3% -$267K ﹤0.01% 2285
2021
Q4 		$17.1M Buy
+51,294
New +$24.4M ﹤0.01% 1890

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Northern Trust's DNA Position: Q2 2026 in Review

Northern Trust increased its Ginkgo Bioworks (DNA) stake by 21% in Q2 2026, buying an estimated $593K and bringing the position to 405,141 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Northern Trust first reported a position in DNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $17.1M in Q4 2021. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Northern Trust held 405,141 shares of Ginkgo Bioworks worth $4.01M as of Q2 2026.
  • Northern Trust bought 70,963 Ginkgo Bioworks shares in Q2 2026, an estimated $593K.
  • Ginkgo Bioworks made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2743 holding.
  • Northern Trust first reported a position in Ginkgo Bioworks in Q4 2021 and has held it in 19 quarters since.
  • Northern Trust's Ginkgo Bioworks position peaked at $17.1M in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.